Distribution of EGFR and KRAS Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review

Our findings improve the understanding of lung cancer genetics in a small and homogeneous area of Southern Italy and guide future research. The <i>EGFR</i> and <i>KRAS</i> mutations in NSCLC resected patients from Southern Italy showed a global similar incidence compared to other recently described Italian cohorts of advanced and early-stage NSCLC, with a higher frequency of exon19 <i>EGFR</i> deletions. No prognostic impact was observed for both <i>EGFR</i> and <i>KRAS</i> status, but additional investigations on a larger cohort are needed.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-02-21
DOI
https://doi.org/10.3390/cancers17050730
Citations
2
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
3.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Distribution of EGFR and KRAS Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review

Fabiola Fiordelisi, Flavia Centra, Paola Parente, Marco Donatello Delcuratolo et al.
2 citations
Cancers
Lung Cancer Treatments and Mutations
3.04
article

Distribution of EGFR and KRAS Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review

Fabiola Fiordelisi, Flavia Centra, Paola Parente, Marco Donatello Delcuratolo, Lucia Anna Muscarella, Paolo Graziano, Federico Pio Fabrizio, Mario Mastroianno, Concetta Martina Di Micco, Michele Piazzolla, Antonella Centonza, Francesco Delli Muti, Gianmaria Ferretti
article en
2 citations

Abstract

Our findings improve the understanding of lung cancer genetics in a small and homogeneous area of Southern Italy and guide future research. The <i>EGFR</i> and <i>KRAS</i> mutations in NSCLC resected patients from Southern Italy showed a global similar incidence compared to other recently described Italian cohorts of advanced and early-stage NSCLC, with a higher frequency of exon19 <i>EGFR</i> deletions. No prognostic impact was observed for both <i>EGFR</i> and <i>KRAS</i> status, but additional investigations on a larger cohort are needed.

CancersVol. 17(5)
Casa Sollievo della Sofferenza (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Ministero della Salute
Good health and well-being
Openalex Percentile: Top 11%
Lung Cancer Treatments and Mutations
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Distribution of EGFR and KRAS Mutations in Patients with Surgically Resected Non-Small Cell Lung Cancer from Southern Italy: Real-Life Data from a Single Institution and Literature Review — Fabiola Fiordelisi, Flavia Centra, et al. · Cancers (2025) | TGRS Research Map | TGRS